Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 90

Similar articles for PubMed (Select 25015913)

1.

High levels of alcohol consumption increase the risk of advanced hepatic fibrosis in HIV/hepatitis C virus-coinfected patients: a sex-based analysis using transient elastography at enrollment in the HEPAVIH ANRS CO13 cohort.

Marcellin F, Roux P, Loko MA, Lions C, Caumont-Prim A, Dabis F, Salmon-Ceron D, Spire B, Carrieri MP; HEPAVIH (ANRS CO13) Study Group.

Clin Infect Dis. 2014 Oct 15;59(8):1190-2. doi: 10.1093/cid/ciu525. Epub 2014 Jul 11. No abstract available.

PMID:
25015913
2.

Efficacy and safety of etravirine-containing regimens in a large cohort of HIV/HCV coinfected patients according to liver fibrosis.

Casado JL, Mena A, Bañón S, Moreno A, Castro A, Perez-Elías MJ, Pedreira J, Moreno S.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19574. doi: 10.7448/IAS.17.4.19574. eCollection 2014.

3.

Using patient-reported outcomes to improve the management of co-infection with HIV and HCV: the ANRS CO13 HEPAVIH cohort.

Marcellin F, Roux P, Winnock M, Lions C, Dabis F, Salmon-Ceron D, Loko MA, Spire B, Carrieri MP.

Expert Rev Gastroenterol Hepatol. 2014 May;8(4):351-8. doi: 10.1586/17474124.2014.888949. Epub 2014 Mar 3. Review.

PMID:
24580042
4.

[Using transient elastography as a screening tool for liver fibrosis in addiction service].

Lahmek P, Meunier N, Michel L, Aubin HJ, Balester-Mouret S.

Presse Med. 2014 Mar;43(3):e17-31. doi: 10.1016/j.lpm.2013.07.027. Epub 2014 Jan 31. French.

PMID:
24485827
5.

Progression of liver fibrosis in HIV/hepatitis C virus-coinfected individuals on antiretroviral therapy with early stages of liver fibrosis at baseline.

Sanmartín R, Tor J, Sanvisens A, López JJ, Jou A, Muga R, Ojanguren I, Barluenga E, Videla S, Planas R, Clotet B, Tural C.

HIV Med. 2014 Apr;15(4):203-12. doi: 10.1111/hiv.12105. Epub 2013 Nov 19.

PMID:
24245909
6.

Impact of HCV treatment and depressive symptoms on adherence to HAART among HIV-HCV-coinfected patients: results from the ANRS-CO13-HEPAVIH cohort.

Roux P, Lions C, Cohen J, Winnock M, Salmon-Céron D, Bani-Sadr F, Sogni P, Spire B, Dabis F, Carrieri MP; ANRS-CO13-HEPAVIH Study Group.

Antivir Ther. 2014;19(2):171-8. doi: 10.3851/IMP2699. Epub 2013 Oct 28.

PMID:
24166726
7.

Characterization of CD4⁺ T-cell immune activation and interleukin 10 levels among HIV, hepatitis C virus, and HIV/HCV-coinfected patients.

Hodowanec AC, Brady KE, Gao W, Kincaid SL, Plants J, Bahk M, Landay AL, Huhn GD.

J Acquir Immune Defic Syndr. 2013 Nov 1;64(3):232-40. doi: 10.1097/QAI.0b013e31829c6de0.

PMID:
24131865
8.

Comparison of transient elastography (FibroScan), FibroTest, APRI and two algorithms combining these non-invasive tests for liver fibrosis staging in HIV/HCV coinfected patients: ANRS CO13 HEPAVIH and FIBROSTIC collaboration.

Castera L, Winnock M, Pambrun E, Paradis V, Perez P, Loko MA, Asselineau J, Dabis F, Degos F, Salmon D.

HIV Med. 2014 Jan;15(1):30-9. doi: 10.1111/hiv.12082. Epub 2013 Sep 6.

PMID:
24007567
9.

Association between elevated coffee consumption and daily chocolate intake with normal liver enzymes in HIV-HCV infected individuals: results from the ANRS CO13 HEPAVIH cohort study.

Carrieri MP, Lions C, Sogni P, Winnock M, Roux P, Mora M, Bonnard P, Salmon D, Dabis F, Spire B; ANRS CO13 HEPAVIH Study Group.

J Hepatol. 2014 Jan;60(1):46-53. doi: 10.1016/j.jhep.2013.08.014. Epub 2013 Aug 24.

PMID:
23978720
10.

Risk of liver decompensation among HIV/hepatitis C virus-coinfected individuals with advanced fibrosis: implications for the timing of therapy.

Macías J, Márquez M, Téllez F, Merino D, Jiménez-Aguilar P, López-Cortés LF, Ortega E, von Wichmann MA, Rivero A, Mancebo M, Santos J, Pérez-Pérez M, Suárez-Lozano I, Romero-Palacios A, Torres-Cornejo A, Pineda JA.

Clin Infect Dis. 2013 Nov;57(10):1401-8. doi: 10.1093/cid/cit537. Epub 2013 Aug 14.

11.

Association of HIV infection, hepatitis C virus infection, and metabolic factors with liver stiffness measured by transient elastography.

Bailony MR, Scherzer R, Huhn G, Plankey MW, Peters MG, Tien PC.

J Infect Dis. 2013 Dec 1;208(11):1776-83. doi: 10.1093/infdis/jit357. Epub 2013 Jul 30.

12.

Liver fibrosis progression in chronic hepatitis B patients positive for hepatitis B e antigen: a prospective cohort study with paired transient elastography examination.

Wong GL, Chan HL, Yu Z, Chan HY, Tse CH, Wong VW.

J Gastroenterol Hepatol. 2013 Nov;28(11):1762-9. doi: 10.1111/jgh.12312.

PMID:
23808759
13.

Prediction of hepatic fibrosis in patients coinfected with HIV and hepatitis C virus based on genetic markers.

Fernández-Rodríguez A, Berenguer J, Jiménez-Sousa MA, Guzmán-Fulgencio M, Micheloud D, Miralles P, López JC, Bellón JM, Aldamiz-Echevarria T, García-Broncano P, Carrero A, Alvarez E, Resino S.

J Acquir Immune Defic Syndr. 2013 Dec 15;64(5):434-42. doi: 10.1097/QAI.0b013e3182a06eb6.

PMID:
23797694
14.

Liver stiffness measurement versus liver biopsy to predict survival and decompensations of cirrhosis among HIV/hepatitis C virus-coinfected patients.

Macías J, Camacho A, Von Wichmann MA, López-Cortés LF, Ortega E, Tural C, Ríos MJ, Merino D, Téllez F, Márquez M, Mancebo M, Pineda JA.

AIDS. 2013 Oct 23;27(16):2541-9. doi: 10.1097/QAD.0b013e32836381f3.

PMID:
23736148
15.

HIV, age, and the severity of hepatitis C virus-related liver disease: a cohort study.

Kirk GD, Mehta SH, Astemborski J, Galai N, Washington J, Higgins Y, Balagopal A, Thomas DL.

Ann Intern Med. 2013 May 7;158(9):658-66. doi: 10.7326/0003-4819-158-9-201305070-00604.

16.

Self-reported alcohol abuse in HIV-HCV co-infected patients: a better predictor of HIV virological rebound than physician's perceptions (HEPAVIH ARNS CO13 cohort).

Marcellin F, Lions C, Winnock M, Salmon D, Durant J, Spire B, Mora M, Loko MA, Dabis F, Dominguez S, Roux P, Carrieri MP; ANRS CO13 HEPAVIH Study Group.

Addiction. 2013 Jul;108(7):1250-8. doi: 10.1111/add.12149. Epub 2013 Mar 21.

PMID:
23421419
17.

Liver stiffness predicts liver-related complications and mortality in HIV patients with chronic hepatitis C on antiretroviral therapy.

Fernández-Montero JV, Barreiro P, Vispo E, Labarga P, Sánchez-Parra C, Soriano V.

AIDS. 2013 Apr 24;27(7):1129-34. doi: 10.1097/QAD.0b013e32835e063f.

PMID:
23276803
18.

Low vitamin D levels are associated with impaired virologic response to PEGIFN + RBV therapy in HIV-hepatitis C virus coinfected patients.

Mandorfer M, Reiberger T, Payer BA, Ferlitsch A, Breitenecker F, Aichelburg MC, Obermayer-Pietsch B, Rieger A, Trauner M, Peck-Radosavljevic M; Vienna HIV & Liver Study Group.

AIDS. 2013 Jan 14;27(2):227-32. doi: 10.1097/QAD.0b013e32835aa161.

PMID:
23238552
19.

IL28B polymorphism, blood interferon-alpha concentration, and disease stage of HCV mono-infected and HCV-HIV co-infected patients.

Burlone ME, Cerutti A, Minisini R, Smirne C, Boccato E, Ceriani E, Rizzo G, Bargiacchi O, Bocchetta S, Occhino G, Pirisi M.

Curr HIV Res. 2013 Jan;11(1):50-5.

PMID:
23237012
20.

A cross-sectional epidemiological study of chronic HCV liver disease stage in HIV-coinfected patients using noninvasive techniques: CoTrans- GEENI Study.

Ramírez R, Valero S, Escrich C, Cucurull J, Tapiz A, Pedrol E, Cotrans-Geeni Study Group.

Curr HIV Res. 2012 Dec;10(8):688-93.

PMID:
23092198
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk